| Journal | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation |
| Study Type | Randomized Trial |
| Population | Human participants |
This is the first comprehensive meta-analysis examining health-related quality of life outcomes across all chronic conditions treated with medicinal cannabis, providing much-needed standardization of outcome measurement. Quality of life represents a primary treatment goal for most patients seeking cannabis therapy, yet has been inconsistently measured and reported in clinical trials.
This systematic review and meta-analysis examined validated HRQL measures in medicinal cannabis studies from 2015-2025 across multiple databases. The authors evaluated how studies justified, measured, and reported quality of life outcomes, conducting separate meta-analyses for short-term (2 weeks-3 months), medium-term (3-12 months), and long-term (≥12 months) follow-up periods. Risk of bias assessment was performed for randomized controlled trials. The study addresses a critical gap in cannabis research by standardizing quality of life outcome measurement across diverse chronic health conditions.
“I’ve long observed that patients consistently report improved quality of life with cannabis therapy, but we’ve lacked rigorous synthesis of this evidence across conditions and timeframes. This meta-analysis provides the systematic framework clinicians need to counsel patients about realistic HRQL expectations.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Does medicinal cannabis improve quality of life in patients with chronic conditions?
- How long does it take to see quality of life improvements with medicinal cannabis?
- What chronic conditions were studied for quality of life outcomes with medicinal cannabis?
- How reliable is the evidence for quality of life improvements with medicinal cannabis?
- What should clinicians consider when evaluating medicinal cannabis for patient quality of life?
FAQ
Does medicinal cannabis improve quality of life in patients with chronic conditions?
This systematic review and meta-analysis found evidence that medicinal cannabis can improve health-related quality of life (HRQL) in patients with chronic health conditions. The analysis examined both short-term (2 weeks to 3 months) and longer-term outcomes using validated HRQL measurement tools.
How long does it take to see quality of life improvements with medicinal cannabis?
The study analyzed HRQL outcomes across three time periods: short-term (2 weeks to 3 months), medium-term (3 to 12 months), and long-term (12+ months). Evidence suggests quality of life improvements can be observed within the short-term period, though the durability and magnitude of benefits may vary by time frame.
What chronic conditions were studied for quality of life outcomes with medicinal cannabis?
The systematic review included studies examining medicinal cannabis for any chronic health condition, with chronic pain being specifically highlighted as a focus area. The research encompassed various chronic conditions where patients experience reduced quality of life and may benefit from medicinal cannabis therapy.
How reliable is the evidence for quality of life improvements with medicinal cannabis?
The study used validated HRQL measurement tools and assessed risk of bias in randomized controlled trials to ensure evidence quality. The systematic review methodology, including independent screening by two reviewers and meta-analysis of primary research, provides a robust evidence base for clinical decision-making.
What should clinicians consider when evaluating medicinal cannabis for patient quality of life?
Clinicians should use validated HRQL measurement tools to assess baseline quality of life and monitor treatment response over time. The evidence supports considering medicinal cannabis as a treatment option for chronic conditions where conventional therapies may be insufficient, with careful attention to patient-reported outcomes and individualized treatment approaches.